Niagen Bioscience (NAGE) Leases: 2019-2025
Historic Leases for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to $2.4 million.
- Niagen Bioscience's Leases rose 26.32% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 26.32%. This contributed to the annual value of $1.7 million for FY2024, which is 27.92% down from last year.
- As of Q3 2025, Niagen Bioscience's Leases stood at $2.4 million, which was down 4.95% from $2.5 million recorded in Q2 2025.
- In the past 5 years, Niagen Bioscience's Leases ranged from a high of $4.4 million in Q4 2021 and a low of $1.7 million during Q4 2024.
- In the last 3 years, Niagen Bioscience's Leases had a median value of $2.4 million in 2025 and averaged $2.5 million.
- Per our database at Business Quant, Niagen Bioscience's Leases surged by 353.90% in 2021 and then tumbled by 36.73% in 2024.
- Over the past 5 years, Niagen Bioscience's Leases (Quarterly) stood at $4.4 million in 2021, then decreased by 19.93% to $3.5 million in 2022, then crashed by 31.88% to $2.4 million in 2023, then fell by 27.92% to $1.7 million in 2024, then grew by 26.32% to $2.4 million in 2025.
- Its Leases stands at $2.4 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.7 million for Q1 2025.